FDA Center for Drug Evaluation & Research Issues Warning Letter to Altru Telehealth
June 17, 2026
June 17, 2026
WASHINGTON, June 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Altru Telehealth LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Altru Telehealth, LLC dba Altru Telehealth, 5000 Thayer Center, Oakland, MD 21550, United States, hello@altrutelehealth.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
* * *
Recipient: Altru Telehealth, LLC dba Altru Telehealth, 5000 Thayer Center, Oakland, MD 21550, United States, hello@altrutelehealth.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER